5-APB Facts
Stimulant;
Description
5-APB (5-(2-aminopropyl)benzofuran) — Benzofury — is a synthetic entactogen-stimulant of the benzofuran class. It floods the brain with serotonin, dopamine, and norepinephrine, combining entactogenic warmth with mild psychedelic effects.[1]
Subjective effects include emotional warmth, empathogenic openness, sensory enhancement, mild geometric visuals, and cognitive euphoria. The experience sits between MDMA and MDA — more perceptually active and introspective than MDMA, warmer and more sociable than a classical psychedelic.
Dependence is moderate, comparable to MDMA; the lethal dose is unknown, with only two documented human deaths to bracket the range.[2][3] The greatest long-term risk is heart valve damage from sustained serotonin receptor activation,[4][5] and a triple serotonergic mechanism makes poisoning easier to trigger than with MDMA.[1]
Dose and durationby route · individual sensitivity varies
Starts in 20 – 45 minLasts 5 – 8 hoursAfter-effects 12 – 72 hours
Body and dependence
- Acute toxicity
- High
- Chronic toxicity
- High
- Physical dependence
- Low
- Psychological dependence
- Moderate
- Withdrawal
- Mild
- Compulsive redosing
- Low
Tolerance
- Builds
- Moderate
- Fully resets after
- 10 days
- Carries over to
- MDMA;
MDA; 6-APB; 5-MAPB; 6-MAPB
Effectslikely at a common dose
- Perception
- Music enhancement;
Touch enhancement; +9 possible - Body
- Stimulation;
Wakefulness; Appetite suppression; Body high; Body scan awareness; Pupil dilation; Spontaneous body sensations; Tactile euphoria; +19 possible, including Insomnia, Muscle tension, Bruxism - Thinking
- Cognitive euphoria;
Aesthetic enhancement; Introspection enhancement; Openness enhancement; +21 possible, including Compulsive redosing urge, Suggestibility enhancement - Feeling
- Empathy enhancement;
Emotional enhancement; Euphoria; +9 possible, including Depression, Anhedonia, Anxiety - Self
- Communication enhancement;
Disinhibition; Sociability enhancement; Social connection; Trust enhancement; +3 possible, including Craving - Time
- Present-moment absorption;
+1 possible - Transpersonal
- none likely · 1 possible
- Awareness
- none likely · 3 possible
Who shouldn't take it
Combinations61 recorded
Seek help immediately if
- Overheating / very high body temperature — heavy sweating, then hot dry skin (the leading cause of MDMA deaths, worse when dancing in hot venues)
- Muscle rigidity, jaw clenching, tremor, or twitching (possible serotonin syndrome)
- Fast, pounding heartbeat; chest pain
- Agitation, confusion; seizures
- Hyponatremia (water intoxication) — headache, confusion, drowsiness, vomiting, and seizures from drinking too much water
- Nausea/vomiting; collapse or unconsciousness
What to do
- Move them somewhere cool and help them cool down — overheating is the main danger
- Sip water to stay hydrated but DO NOT overdrink — roughly a cup (250 ml) per hour if active; too much water can be deadly (hyponatremia)
- Get them to rest and stop dancing
- For overheating, seizures, chest pain, muscle rigidity/tremor, confusion, or unresponsiveness, call emergency services
- Recovery position if drowsy or vomiting; stay with them
- Be ready to give rescue breaths / CPR
Most resolve with cooling, rest, sensible hydration, and time. The life-threatening dangers are hyperthermia, serotonin syndrome, and hyponatremia (too much water) — each a medical emergency, not something to wait out.
988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE
References
- [1]^abShimshoni JA, Winkler I, Golan E, Nutt D (2017) Neurochemical binding profiles of novel indole and benzofuran MDMA analogues — Naunyn-Schmiedeberg's Archives of Pharmacology doi:10.1007/s00210-016-1297-4
- [2]^Krpo M, Luytkis HC, Haneborg AM, Høiseth G (2018) A fatal blood concentration of 5-APB — Forensic Science International doi:10.1016/j.forsciint.2018.08.044
- [3]^Adamowicz P, Zuba D, Byrska B (2014) Fatal intoxication with 3-methyl-N-methylcathinone (3-MMC) and 5-(2-aminopropyl)benzofuran (5-APB) — Forensic science international doi:10.1016/j.forsciint.2014.10.016
- [4]^Iversen L, Gibbons S, Treble R, Setola V, Huang XP, Roth BL (2013) Neurochemical profiles of some novel psychoactive substances — European Journal of Pharmacology doi:10.1016/j.ejphar.2012.12.006
- [5]^Rickli A, Kopf S, Hoener MC, Liechti ME (2015) Pharmacological profile of novel psychoactive benzofurans — British Journal of Pharmacology doi:10.1111/bph.13128